For our November Member Spotlight, we’re featuring Celerion, a global leader in early clinical research and bioanalytical services.
Tell us about your company.
Celerion is a world leader in early clinical research and bioanalytical testing services. With more than 50 years of experience, we combine medical expertise, clinical operations, and scientific innovation to help pharmaceutical and biotechnology companies make confident, data-driven decisions early in drug development. Our mission remains the same: to help our clients get life-changing treatments to market faster thereby improving health outcomes for people around the world.
What products and services do you offer?
Celerion provides a comprehensive range of early-phase clinical and bioanalytical services. Our bioanalytical laboratories deliver industry-leading quantitative and qualitative analyses of small molecules, biologics, and emerging modalities, including oligonucleotides, peptides, and cell and gene therapies. We conduct studies from the non-clinical through all clinical phases and aftermarket studies.
We specialize in LC-MS/MS, ligand-binding assays, and flow cytometry for biomarker and immunogenicity testing. These advanced platforms enable highly sensitive and reproducible data to support pharmacokinetic (PK), pharmacodynamic (PD), and safety evaluations throughout drug development.
Alongside our bioanalytical strength, Celerion continues to execute complex first-in-human, drug-drug interaction, and bioequivalence studies, integrating clinical operations with sophisticated data management, biostatistics, and regulatory reporting expertise.
Why is Nebraska an important location for Celerion?
Celerion’s global headquarters in Lincoln, Nebraska, is home to one of our largest clinical research and bioanalytical facilities. Our history here dates to 1933, beginning with Harris Laboratories and evolving through decades of scientific advancement. Nebraska’s strong academic community and workforce talent have played a crucial role in our ability to grow and innovate.
Today, our Lincoln bioanalytical laboratory is a cornerstone of our global network, providing high-quality data and scientific insight that drives decision-making for clients around the world.
How does Celerion recruit and retain talent in Nebraska?
Celerion is deeply committed to developing Nebraska’s scientific workforce. Through partnerships with Southeast Community College, the University of Nebraska and other regional universities, we offer scholarships and hands-on opportunities for students pursuing careers in biotechnology and analytical sciences.
Our Bioanalytical Analyst Progression Program provides structured training and career development for new graduates, ensuring continued professional growth within the organization. We also offer education reimbursement programs, encouraging employees to pursue advanced studies while contributing to our mission.
Beyond Nebraska, how large is Celerion’s footprint?
Celerion operates across North America, Europe, and Asia, with facilities in Lincoln, Phoenix, Belfast, Zurich, Montreal, and Vienna. This global presence allows us to deliver consistent, high-quality data across multiple regulatory environments.
What are some of the biggest challenges in healthcare today, and how does Celerion help address them?
As new therapies become increasingly complex from new biologics medicines to gene and cell therapies, the demand for advanced analytical solutions continues to grow. Celerion is meeting this challenge head-on by investing in new technologies and platforms to support evolving scientific needs.
Through the addition of advanced technologies like the Gyrolab® platform, our laboratories have expanded their bioanalytical capabilities, enabling rapid and highly reproducible immunoassay results for a wide range of biotherapeutic applications. We continue to enhance our expertise in biomarker development, oligonucleotide quantification, and cellular therapy characterization, enabling us to support our clients through every stage of development with precision and speed.
What else should we know about Celerion?
Our people remain our greatest strength. Celerion’s success is built on the experience, innovation, and dedication of our global teams. As we continue to grow our bioanalytical capabilities and invest in scientific excellence, we remain proud to call Nebraska home and to contribute to the state’s thriving life sciences community.
Learn more about Celerion’s bioanalytical capabilities and global research services at celerion.com.